Neuman John 4

What Happened
John Neuman, a director of SeaStar Medical Holding Corp (ticker: ICU), was granted 4,000 restricted stock units (RSUs) on July 1, 2026. The Form 4 reports an acquisition price of $0.00 (total reported value $0). This is a compensation award (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: July 1, 2026; Form 4 filed July 2, 2026 (timely filing).
• Transaction type: Award/Grant (RSU), 4,000 units; reported price $0.00; reported value $0.
• Shares owned after transaction: Not disclosed in the provided filing.
• Footnote: RSUs will vest in full on July 1, 2027 (F1).
• Filing timeliness: Filed the next day — appears timely under Form 4 rules.

Context
RSUs are a form of equity compensation that convert to shares only upon vesting and may be forfeited if vesting conditions aren’t met. The $0 reported price reflects that this was an awarded grant, not a purchase; the economic value will depend on SeaStar’s share price at vesting. Awards are common for directors and are not direct indicators of immediate insider buying or selling sentiment.